Remove Biopharma Remove Leads Remove Pharma Remove Specialization
article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. Speciality pharmacies provide comprehensive medications for individuals with serious medical conditions requiring complex treatments, including cancer, cystic fibrosis, haemophilia, hepatitis, HIV, and others.

article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

Meanwhile, the pharma industry is undergoing somewhat of a transformation itself. For cell and gene therapy applications, you need a variety of speciality enzymes of the highest purity, specificity, and consistency. Developing best-in-class speciality enzymes. The impact could be huge for the biopharma industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Big Pharma deal-making primed for acceleration

European Pharmaceutical Review

After a prolonged period of scepticism towards major moves in the mergers and acquisitions (M&A) market, leading biopharmaceutical multinationals are returning to big deal-making. In addition, and quite significantly, it was “Big Pharma” that was largely responsible for this uptick.

Pharma 69
article thumbnail

Ashfield and Huntsworth Unite to Form Inizio

PM360

Inizio Advisory: This unit helps pharma, biotech, and life sciences companies to develop, execute, and operationalize their strategies across portfolio licensing and development, new product launches, established product and franchise strategy, HEOR, pricing, and market access. Inizio launches with five specialist business units: 1.

article thumbnail

The PM360 Trailblazer Awards 2023 Winners

PM360

PRODUCT LAUNCH OF THE YEAR NEXTSTELLIS (Mayne Pharma and EVERSANA INTOUCH) RELAUNCH/REVITALIZATION OF THE YEAR VRAYLAR (AbbVie Inc. Diversity/Multicultural: Anna Czene, Vice President, Corporate Communications & DEI Lead, CareDx, Inc. and Publicis NY) BRAND CHAMPION AWARD WINNERS Autoimmune/Rheumatology: Katrina Sergeev Gary, Sr.

Education 122
article thumbnail

Medicinal cannabis: the route to good manufacturing practice registration

European Pharmaceutical Review

How do you see the evolution of cannabis-based medicines, particularly when it comes to the ‘specials’ or fully licensed drug routes? For instance, GW Pharma has shown the potential for licensed cannabinoid drugs, building a $7 billion business based around Epidiolex (CBD oil with a small patient population for childhood epilepsy).

Medicine 129
article thumbnail

Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 

Pharmaceutical Technology

Every major pharma company is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. This major difference leads to very different requirements and processes for the clinical trial supply chain, which are summarized below.